Newly Diagnosed Glioblastoma: A Review on Clinical Management.
Journal
Oncology (Williston Park, N.Y.)
ISSN: 0890-9091
Titre abrégé: Oncology (Williston Park)
Pays: United States
ID NLM: 8712059
Informations de publication
Date de publication:
13 Mar 2019
13 Mar 2019
Historique:
entrez:
14
3
2019
pubmed:
14
3
2019
medline:
21
4
2020
Statut:
ppublish
Résumé
Glioblastoma is an aggressive primary tumor of the central nervous system. This review will focus on clinical developments and management of newly diagnosed disease, including a discussion about the incorporation of molecular features into the classification of glioblastoma. Such advances will continue to shape our thinking about the disease and how to best manage it. With regards to treatment, the role of surgical resection, radiotherapy, chemotherapy, and tumor-treating fields will be presented. Pivotal studies defining our current standard of care will be highlighted, as will key ongoing trials that may influence our management of glioblastoma in the near future.
Identifiants
pubmed: 30866031
pii: 623491
pmc: PMC7278092
mid: NIHMS1034869
pii:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
91-100Subventions
Organisme : NINDS NIH HHS
ID : F32 NS073366
Pays : United States
Organisme : NINDS NIH HHS
ID : R00 NS082381
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS097851
Pays : United States
Organisme : NINDS NIH HHS
ID : K99 NS082381
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA221747
Pays : United States
Références
J Neurosurg. 2017 Oct;127(4):781-789
pubmed: 28059657
Sci Transl Med. 2016 Jun 15;8(343):343re2
pubmed: 27306666
J Clin Oncol. 2010 Dec 20;28(36):5287-93
pubmed: 21079138
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):282-90
pubmed: 26908595
J Neurooncol. 2018 Aug;139(1):177-184
pubmed: 29644485
JAMA Oncol. 2018 Apr 1;4(4):495-504
pubmed: 29392280
Brain. 2016 May;139(Pt 5):1458-71
pubmed: 27020328
Lancet Oncol. 2006 May;7(5):392-401
pubmed: 16648043
Curr Mol Pharmacol. 2012 Jan;5(1):102-14
pubmed: 22122467
Genome Res. 2015 Mar;25(3):316-27
pubmed: 25650244
Acta Neuropathol. 2015 Apr;129(4):597-607
pubmed: 25724300
Neuro Oncol. 2018 Mar 27;20(4):472-483
pubmed: 29244145
J Clin Oncol. 2015 Dec 10;33(35):4145-50
pubmed: 26392096
J Neurooncol. 2017 Sep;134(3):487-493
pubmed: 28378194
Neurosurgery. 2015 Aug;62 Suppl 1:160-5
pubmed: 26181937
Acta Neurochir (Wien). 2016 Jan;158(1):51-8
pubmed: 26530708
Cancer Res. 2014 Mar 1;74(5):1440-1451
pubmed: 24390738
Clin Cancer Res. 2016 Oct 1;22(19):4797-4806
pubmed: 27143690
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
Nat Genet. 2016 Jul;48(7):768-76
pubmed: 27270107
World Neurosurg. 2017 Aug;104:239-247
pubmed: 28512039
World Neurosurg. 2015 Apr;83(4):530-42
pubmed: 25524065
Oncotarget. 2017 Sep 11;8(51):89391-89405
pubmed: 29179527
Curr Neurol Neurosci Rep. 2017 Jun;17(6):50
pubmed: 28488122
J Neurol Sci. 2017 Sep 15;380:250-255
pubmed: 28870580
Neuro Oncol. 2011 Apr;13(4):401-9
pubmed: 21324937
Lancet Oncol. 2012 Sep;13(9):916-26
pubmed: 22877848
N Engl J Med. 2005 Mar 10;352(10):997-1003
pubmed: 15758010
Oncologist. 2018 May;23(5):524-e44
pubmed: 29472310
Nat Rev Neurosci. 2005 Jan;6(1):35-47
pubmed: 15611725
Neurosurgery. 2015 Aug;77(2):248-53; discussion 253
pubmed: 25856113
Acta Neuropathol. 2007 Aug;114(2):97-109
pubmed: 17618441
Int J Cancer. 2011 Aug 1;129(3):659-70
pubmed: 21425258
J Neurooncol. 2008 Jul;88(3):339-47
pubmed: 18389177
Nature. 2017 Sep 14;549(7671):227-232
pubmed: 28854171
Neuro Oncol. 2017 Nov 6;19(suppl_5):v1-v88
pubmed: 29117289
J Natl Compr Canc Netw. 2017 Nov;15(11):1331-1345
pubmed: 29118226
J Clin Oncol. 2016 May 10;34(14):1611-9
pubmed: 26976423
Neuro Oncol. 2016 Oct;18(10):1338-49
pubmed: 27664860
J Clin Neurophysiol. 2007 Feb;24(1):1-10
pubmed: 17277570
J Environ Public Health. 2018 Jun 24;2018:7910754
pubmed: 30034480
Neurosurgery. 2018 May 1;82(5):719-727
pubmed: 28645214
Eur J Cancer. 2012 Sep;48(14):2192-202
pubmed: 22608262
J Neurooncol. 2018 Apr;137(2):233-240
pubmed: 29264834
J Neurooncol. 2015 Sep;124(3):333-43
pubmed: 26108656
J Clin Oncol. 2015 Sep 1;33(25):2735-44
pubmed: 26124478
J Clin Oncol. 2008 Mar 10;26(8):1338-45
pubmed: 18323558
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
J Neurosurg. 2001 Aug;95(2):190-8
pubmed: 11780887
J Transl Med. 2018 May 29;16(1):142
pubmed: 29843811
Z Neurol. 1972;201(4):297-309
pubmed: 4113365
Neuro Oncol. 2018 Sep 3;20(10):1300-1309
pubmed: 29452419
Ann Oncol. 2018 Jun 1;29(6):1423-1430
pubmed: 29648580
J Neurosurg. 2008 Feb;108(2):411-21
pubmed: 18240946
Lancet Oncol. 2012 Jul;13(7):707-15
pubmed: 22578793
Neuro Oncol. 2014 Jan;16(1):113-22
pubmed: 24285550
Neuro Oncol. 2003 Apr;5(2):79-88
pubmed: 12672279
J Immunother Cancer. 2018 Jun 11;6(1):51
pubmed: 29891009
N Engl J Med. 2017 Nov 16;377(20):1954-1963
pubmed: 29141164
Eur J Cancer. 2018 Sep;101:95-104
pubmed: 30036741
Curr Oncol Rep. 2017 Aug;19(8):53
pubmed: 28664468
N Engl J Med. 2014 Feb 20;370(8):699-708
pubmed: 24552317
Neuro Oncol. 2014 Jul;16(7):896-913
pubmed: 24842956
Neurochirurgie. 2014 Aug;60(4):143-50
pubmed: 24975207
JAMA. 2015 Dec 15;314(23):2535-43
pubmed: 26670971
J Neurooncol. 2017 Dec;135(3):423-432
pubmed: 29052807
Int Anesthesiol Clin. 1986 Fall;24(3):1-11
pubmed: 3770965
Neuro Oncol. 2014 Jan;16(1):81-91
pubmed: 24305719
J Neurooncol. 2018 Aug;139(1):125-133
pubmed: 29619649
N Engl J Med. 2007 Apr 12;356(15):1527-35
pubmed: 17429084
Neuro Oncol. 2015 Nov;17(11):1425-7
pubmed: 26374690
J Natl Cancer Inst. 2006 Nov 1;98(21):1528-37
pubmed: 17077355
Acta Neuropathol. 2018 Nov;136(5):805-810
pubmed: 30259105
Neurology. 2011 Sep 20;77(12):1156-64
pubmed: 21880994
Eur J Cancer. 2015 Mar;51(4):522-32
pubmed: 25616647
J Neurosurg. 2011 Jul;115(1):3-8
pubmed: 21417701
N Engl J Med. 2008 Jan 3;358(1):18-27
pubmed: 18172171
Front Oncol. 2017 Aug 30;7:196
pubmed: 28913179
J Transl Med. 2018 Jun 29;16(1):179
pubmed: 29958537
Nat Genet. 2018 May;50(5):708-717
pubmed: 29686388
BMC Cancer. 2018 Jan 6;18(1):48
pubmed: 29306321
J Clin Oncol. 2011 Aug 1;29(22):3050-5
pubmed: 21709196
N Engl J Med. 2017 Mar 16;376(11):1027-1037
pubmed: 28296618
Lancet. 2019 Feb 16;393(10172):678-688
pubmed: 30782343
J Neurooncol. 2018 May;138(1):163-171
pubmed: 29423540
Neurooncol Pract. 2017 Dec;4(4):209-219
pubmed: 31385973
Chin Clin Oncol. 2017 Aug;6(4):41
pubmed: 28841803
Neuro Oncol. 2017 Aug 1;19(8):1119-1126
pubmed: 28371907
Neuro Oncol. 2011 Dec;13(12):1339-48
pubmed: 21914639
J Neurooncol. 2019 Mar;142(1):111-118
pubmed: 30535594
Nat Rev Drug Discov. 2016 Apr;15(4):275-92
pubmed: 26794270
J Neurosurg. 2004 Mar;100(3):369-75
pubmed: 15035270
Lancet Oncol. 2014 Sep;15(10):1100-8
pubmed: 25163906
Ann Epidemiol. 2015 Apr;25(4):270-4
pubmed: 25691445
JAMA. 2017 Dec 19;318(23):2306-2316
pubmed: 29260225
Neurosurgery. 2017 Apr 1;80(4):590-601
pubmed: 27509070
Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):835-9
pubmed: 8040031
Lancet Oncol. 2017 Oct;18(10):1373-1385
pubmed: 28844499
J Neurosurg. 1978 Sep;49(3):333-43
pubmed: 355604
J Clin Oncol. 2013 Nov 10;31(32):4085-91
pubmed: 24101040
J Clin Oncol. 2004 May 1;22(9):1583-8
pubmed: 15051755
JAMA. 2012 Nov 14;308(18):1881-8
pubmed: 23099483
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Expert Rev Anticancer Ther. 2017 Jun;17(6):507-515
pubmed: 28438066
Neuro Oncol. 2010 Apr;12(4):320-7
pubmed: 20308310
Front Mol Neurosci. 2018 Feb 21;11:48
pubmed: 29515370
J Neurosurg Sci. 2017 Dec;61(6):612-630
pubmed: 28263047
PLoS One. 2011;6(5):e20041
pubmed: 21625383
J Clin Oncol. 2016 Mar 1;34(7):731-9
pubmed: 26786929
Oncologist. 2010;15(12):1329-34
pubmed: 21147867
Adv Anat Pathol. 2018 May;25(3):143-171
pubmed: 29521646
Nat Med. 2019 Mar;25(3):462-469
pubmed: 30742119
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
N Engl J Med. 2014 Feb 20;370(8):709-22
pubmed: 24552318
JAMA Oncol. 2016 Nov 1;2(11):1460-1469
pubmed: 27310651
J Neurooncol. 2017 Dec;135(3):593-599
pubmed: 28849343